99 related articles for article (PubMed ID: 16643458)
1. The association between FANCD1/BRCA2 mutations and leukaemia.
Alter BP
Br J Haematol; 2006 May; 133(4):446-8; author reply 448. PubMed ID: 16643458
[No Abstract] [Full Text] [Related]
2. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
[TBL] [Abstract][Full Text] [Related]
3. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
4. Inherited FANCD1/BRCA2 exon 7 splice mutations associated with acute myeloid leukaemia in Fanconi anaemia D1 are not found in sporadic childhood leukaemia.
Barber LM; Barlow RA; Meyer S; White DJ; Will AM; Eden TO; Taylor GM
Br J Haematol; 2005 Sep; 130(5):796-7. PubMed ID: 16115142
[No Abstract] [Full Text] [Related]
5. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
Alter BP; Rosenberg PS; Brody LC
J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.
Wagner JE; Tolar J; Levran O; Scholl T; Deffenbaugh A; Satagopan J; Ben-Porat L; Mah K; Batish SD; Kutler DI; MacMillan ML; Hanenberg H; Auerbach AD
Blood; 2004 Apr; 103(8):3226-9. PubMed ID: 15070707
[TBL] [Abstract][Full Text] [Related]
7. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
[TBL] [Abstract][Full Text] [Related]
11. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia.
Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N
Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
[TBL] [Abstract][Full Text] [Related]
13. Treatment With Azacitidine in the Context of Palliative Care for a Patient With Acute Myeloid Leukemia Complicating Fanconi Anemia With Biallelic FANCD1/BRCA 2 Mutations.
Berot A; Pluchart C
J Pediatr Hematol Oncol; 2018 Apr; 40(3):247-248. PubMed ID: 29389832
[No Abstract] [Full Text] [Related]
14. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
[TBL] [Abstract][Full Text] [Related]
15. Biallelic inactivation of BRCA2 in Fanconi anemia.
Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2-induced graft-versus-leukemia for the treatment of AML in a BRCA2 Fanconi anemia patient.
Yeo CJ; Gilman AL
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e78-80. PubMed ID: 23619121
[TBL] [Abstract][Full Text] [Related]
17. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
[TBL] [Abstract][Full Text] [Related]
18. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
[TBL] [Abstract][Full Text] [Related]
19. Biomedicine. D-Day for BRCA2.
Witt E; Ashworth A
Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
[No Abstract] [Full Text] [Related]
20. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
